The statistical tests showed a relationship between the concentrations of ADAM proteins and the clinical stage of CRC, respectively, for ADAM10, p < 0.02, ADAM12, p < 0.03, ADAM17, p < 0.03, and ADAM28, p < 0.005. This evidence concerns the gene ADAM17 and colorectal carcinoma.